These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28427052)

  • 1. Glucosylceramide Critically Contributes to the Host Defense of Cystic Fibrosis Lungs.
    Kovacic B; Sehl C; Wilker B; Kamler M; Gulbins E; Becker KA
    Cell Physiol Biochem; 2017; 41(3):1208-1218. PubMed ID: 28427052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon regulatory factor 8 regulates expression of acid ceramidase and infection susceptibility in cystic fibrosis.
    Gardner AI; Wu Y; Verhaegh R; Liu Y; Wilker B; Soddemann M; Keitsch S; Edwards MJ; Haq IJ; Kamler M; Becker KA; Brodlie M; Gulbins E
    J Biol Chem; 2021; 296():100650. PubMed ID: 33839155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-specific modeling of regional antibiotic concentration levels in airways of patients with cystic fibrosis: are we dosing high enough?
    Bos AC; van Holsbeke C; de Backer JW; van Westreenen M; Janssens HM; Vos WG; Tiddens HA
    PLoS One; 2015; 10(3):e0118454. PubMed ID: 25734630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis.
    Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E
    Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
    Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid Ceramidase Rescues Cystic Fibrosis Mice from Pulmonary Infections.
    Becker KA; Verhaegh R; Verhasselt HL; Keitsch S; Soddemann M; Wilker B; Wilson GC; Buer J; Ahmad SA; Edwards MJ; Gulbins E
    Infect Immun; 2021 Jan; 89(2):. PubMed ID: 33139382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
    Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
    J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils Kill Reactive Oxygen Species-Resistant Pseudomonas aeruginosa by Sphingosine.
    Becker KA; Li X; Seitz A; Steinmann J; Koch A; Schuchman E; Kamler M; Edwards MJ; Caldwell CC; Gulbins E
    Cell Physiol Biochem; 2017; 43(4):1603-1616. PubMed ID: 29040968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Inhaled Sphingosine for Treating Lung Infection in a Mouse Model of Critical Illness.
    Beckmann N; Pugh AM; Auteri NJ; Edwards MJ; Gulbins E; Caldwell CC
    Cell Physiol Biochem; 2020 Oct; 54(5):1054-1067. PubMed ID: 33080125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis.
    Moore JE; Mastoridis P
    J Clin Pharm Ther; 2017 Jun; 42(3):259-267. PubMed ID: 28374433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-fragmentation is a source of bactericidal activity against Pseudomonas aeruginosa.
    Bhongir RK; Kasetty G; Papareddy P; Mörgelin M; Herwald H; Egesten A
    Biochem J; 2017 Feb; 474(3):411-425. PubMed ID: 27784762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.
    Coleman FT; Mueschenborn S; Meluleni G; Ray C; Carey VJ; Vargas SO; Cannon CL; Ausubel FM; Pier GB
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1949-54. PubMed ID: 12578988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobramycin inhalation powder (TOBI Podhaler) for the treatment of lung infection in patients with cystic fibrosis.
    Vazquez-Espinosa E; Marcos C; Alonso T; Giron RM; Gomez-Punter RM; Garcia-Castillo E; Zamora E; Cisneros C; Garcia J; Valenzuela C; Ancochea J
    Expert Rev Anti Infect Ther; 2016; 14(1):9-17. PubMed ID: 26559549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis.
    Yu H; Nasr SZ; Deretic V
    Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the Novel Antibiotic POL7001 in Preclinical Models of Pseudomonas aeruginosa Pneumonia.
    Cigana C; Bernardini F; Facchini M; Alcalá-Franco B; Riva C; De Fino I; Rossi A; Ranucci S; Misson P; Chevalier E; Brodmann M; Schmitt M; Wach A; Dale GE; Obrecht D; Bragonzi A
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4991-5000. PubMed ID: 27297477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model.
    Thomsen K; Christophersen L; Lerche CJ; Holmgaard DB; Calum H; Høiby N; Moser C
    Int J Antimicrob Agents; 2021 Jan; 57(1):106213. PubMed ID: 33256950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
    Strateva T; Petrova G; Mitov I
    J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
    Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of Sphingosine Causes Susceptibility to Pulmonary Staphylococcus Aureus Infections in Cystic Fibrosis.
    Tavakoli Tabazavareh S; Seitz A; Jernigan P; Sehl C; Keitsch S; Lang S; Kahl BC; Edwards M; Grassmé H; Gulbins E; Becker KA
    Cell Physiol Biochem; 2016; 38(6):2094-102. PubMed ID: 27184795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.